Proposed Re-evaluation Decision PRVD2020-10, Kresoxim-methyl and Its Associated End-use Products
This document (PRVD2020-10, Kresoxim-methyl and Its Associated End-use Products) presents the proposed regulatory decision for the re-evaluation of kresoxim-methyl including the proposed risk mitigation measures to further protect human health and the environment , as well as the science evaluation on which the proposed decision was based.
- Publisher - Current Organization Name: Health Canada
- Licence: Open Government Licence - Canada
Data and Resources
-
Proposed Re-evaluation Decision PRVD2020-10, Kresoxim-methyl and Its Associated End-use ProductsHTMLEnglish publication HTML
Similar records